SARS-CoV-2 serology by mild symptoms of disease

SARS-CoV-2 serology by mild symptoms of disease - SARS-CoV-2 serology

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON50020

Enrollment

Registered

2020-05-24

Start date

2020-06-15

Completion date

Unknown

Last updated

2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

SARS-CoV-2 infection

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 18 years or older Abliity to read and understand informed consent Proven SARS-CoV-2 infection more than three weeks ago. No hospitalisation for more than three month No clinical symptoms of active infection at the time of bloodsampling

Exclusion criteria

Exclusion criteria: age of 17 years or younger Unable to read the informed consent

Design outcomes

Primary

Measure	Time frame
Sensitivity of the diverse assays in a population of patients with mild symptoms.	—

Countries

Netherlands

Outcome results